Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study

Author:

Palmirotta Raffaele1,Barbanti Piero2,Ludovici Giorgia1,De Marchis Maria Laura1,Ialongo Cristiano3,Egeo Gabriella2,Aurilia Cinzia2,Fofi Luisa2,Abete Pasquale4,Spila Antonella1,Ferroni Patrizia1,Della-Morte David5,Guadagni Fiorella1

Affiliation:

1. Interinstitutional Multidisciplinary BioBank (BioBIM), Department of Advanced Biotechnologies & Bioimaging, IRCCS San Raffaele Pisana, Rome, Italy

2. Headache & Pain Unit, Department of Neurological, Motor & Sensorial Sciences, IRCCS San Raffaele Pisana, Via Della Pisana 235, Rome 00163, Italy

3. Department of Internal Medicine, University of Rome ‘Tor Vergata’, Medicine & Surgery, Via Montpellier, 1, Rome 00133, Italy

4. Department of Translational Medical Sciences, University of Naples Federico II, Napoli 80131, Italy

5. Department of Systems Medicine, University of Rome ‘Tor Vergata’, Medicine & Surgery, Via Montpellier, 1, Rome 00133, Italy.

Abstract

Aim: In the present case–control study, we investigated the correlation between the common ACE insertion/deletion (I/D) polymorphism and migraine. Materials & methods: Genotyping of the ACE I/D variant was performed in 502 Caucasian patients with migraine and 323 age-, sex- and race/ethnicity-matched healthy controls. We investigated associations between ACE genetic variants and sociodemographic and/or clinical features of migraineurs. Results: We found a significant association between ACE insertion/insertion (I/I) polymorphism and lower use of pharmacological prophylaxis in migraine patients with aura and in those with chronic migraine. Moreover, ACE I/I polymorphism was significantly more common in migraine patients with aura who had a negative family history of migraine. Conclusion: Our data suggest that although the ACE I/D polymorphism is not a direct risk factor for migraine, the ACE I/I genotype may influence the clinical feature of this disease being associated with reduced use of prophylactic agents in patients with migraine with aura and in those with chronic migraine. Original submitted 5 June 2013; Revision submitted 16 September 2013

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3